Hyperfine (HYPR) Operating Margin (QoQ) (2021 - 2026)
Hyperfine (HYPR) Operating Margin (QoQ) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn |
| 10 | Hyperfine | 90.65 Mn | 45.88 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 234.00 |
| Mar 31, 2026 | -7,440.00 |
| Dec 31, 2025 | 11,466.00 |
| Sep 30, 2025 | 9,637.00 |
| Jun 30, 2025 | 15,426.00 |
| Mar 31, 2025 | -4,635.00 |
| Dec 31, 2024 | -16,288.00 |
| Sep 30, 2024 | -223.00 |
| Jun 30, 2024 | 2,451.00 |
| Mar 31, 2024 | 10,973.00 |
| Dec 31, 2023 | 7,173.00 |
| Sep 30, 2023 | -15,886.00 |
| Jun 30, 2023 | 14,887.00 |
| Mar 31, 2023 | 46,241.00 |
| Dec 31, 2022 | -39,142.00 |
| Sep 30, 2022 | 94,718.00 |
| Jun 30, 2022 | 6,243.00 |
| Mar 31, 2022 | 440,798.00 |
| Dec 31, 2021 | -156,547.00 |
| Sep 30, 2021 | -34,349.00 |